You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy

Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response

A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients

Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions

The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy

Molecular insight into targeting the NK cell immune response to cancer

The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

IL-15 signaling in NK cell cancer immunotherapy